Massive New Study Reveals How Psychedelics Actually Reorganize the Human Brain

Psychedelics are making the brain's hierarchies flatter and more democratic.

by · ZME Science
AI-generated image.

You’ve likely seen some of the headlines: psychedelics aren’t just for getting high, they’re showing real medical promise. In some fields (like PTSD and addiction), they’re even being heralded as the next frontier of mental health. But if we’re being honest, it’s often hard to know where the hype ends and where the real scientific potential begins,

That’s because studying these drugs is a nightmare. For decades, red tape kept labs locked. When the gates finally opened, we were left with small, scattered studies that rarely agreed on the details.

Now, an international team of researchers has finally stepped in to add up all the info we have. They formed the BOLD Psychedelic Consortium and conducted a mega-analysis that integrates 11 independent datasets across five different drugs — psilocybin, LSD, mescaline, DMT, and the potent brew ayahuasca. This massive effort spanned three continents and five countries, involving 267 unique participants and over 500 individual brain scans.

The biggest takeaway? Psychedelics effectively “flatten” the brain’s organizational hierarchy.

Who Runs the Brain?

Under ordinary conditions, the brain is organized into networks with different jobs. Some are closely tied to sensation and movement: vision, touch, action. Others are more abstract, involved in memory, planning, self-reflection and the management of attention. This is all very hierarchical, with sensory systems at the bottom of the executive chain and the more complex system on top.

The new analysis found that psychedelics bridge these worlds and shatter the hierarchy.

They increase functional connectivity, meaning the parts of your brain responsible for deep introspection start talking directly to the parts handling your senses and body. Simply put, the brain’s hierarchy collapses. The usual chain of command is relaxed and some signals are allowed to pass straight to the executive regions unfiltered.

That result fits with a long-running idea in psychedelic neuroscience: these drugs may relax the brain’s normal chain of command. But this doesn’t mean that every prior claim is confirmed.

×

Get smarter every day...

Stay ahead with ZME Science and subscribe.

Daily Newsletter
The science you need to know, every weekday.

Weekly Newsletter
A week in science, all in one place. Sends every Sunday.
No spam, ever. Unsubscribe anytime. Review our Privacy Policy.

Thank you! One more thing...

Please check your inbox and confirm your subscription.

Tearing Down the Brain’s Ivory Towers

For years, researchers claimed psychedelics simply weakened connectivity within the brain. This new data suggests that’s not quite right. Instead of a sweeping collapse, the researchers saw a focused reorganization.

Of course, not every drug acts the same.

With the larger psilocybin and LSD datasets, the results were more stable, so the authors can be more confident those drugs share a real brain-connectivity pattern. Mescaline seemed to do something similar, but the evidence was less consistent. DMT looked like it caused very strong changes, but because there were fewer participants, the researchers cannot be as sure those big effects would hold up in larger studies.

Among the five substances, Ayahuasca looked the most different, though researchers note that may not mean it truly acts in a completely unique way. It may partly reflect the fact that the study was very small and that ayahuasca is chemically more complex than pure DMT, because it includes other substances that alter how DMT is absorbed and affects the brain.

RelatedPosts

Psychedelics May Alleviate Death Anxiety by Shifting Beliefs
Cannabis may help you sleep better. But there’s a catch
How Handing Smartphones to Kids Before They Turn 13 May Damage Their Mental Health for Life
Ibogaine, a psychedelic used in shamanistic rituals gives rise to new drugs that treat depression and addiction

The team also concludes that what emerges is a brain that is not merely disordered under psychedelics, but reorganized. Its usual lines of communication appear to loosen, especially between systems that normally keep some distance from one another.

This research could prove instrumental in figuring out exactly how psychedelics help the brain escape some of its problems. For instance, for someone trapped in the rigid, repetitive loops of deep depression or OCD, the brain’s hierarchy can feel less like an organizational tool and more like a prison. By proving that psychedelics flatten this structure, we’re seeing the physical mechanism of a mental reset.

That isn’t a full explanation. But for a field long divided by scattered findings, it is a meaningful step toward a common map.